CONMED Corporation Announces Fourth Quarter and Fiscal Year 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Leerink Partners Remains Bullish as Conmed's (CNMD) Growth Acceleration Shows Evolving Turnaround
January 28, 2016 10:10 AM ESTLeerink Partners reiterated an Outperform rating on CONMED (NASDAQ: CNMD), and cut the price target to $50.00 (from $51.00), following the company's 4Q report. Results were marked by solid growth acceleration in ortho and in Leerink's view, the Surgiquest acquisition should be an important catalyst for the... More
Conmed (CNMD) Tops Q4 EPS by 1c; Guides
January 27, 2016 4:24 PM ESTConmed (NASDAQ: CNMD) reported Q4 EPS of $0.52, $0.01 better than the analyst estimate of $0.51. Revenue for the quarter came in at $191 million versus the consensus estimate of $191.03 million.
GUIDANCE:
Conmed sees FY2016 EPS of $1.85-$1.95, versus the consensus of $1.80. Conmed sees FY2016... More
